UK Tests Faster Ethics Review Of Non COVID-19 Trials
Pilot Aims To Deliver Final Ethics Opinion In 15 Days
The UK’s Health Research Authority is testing whether clinical trial sponsors have an appetite for a new rapid ethics review service covering non COVID-19 research.
You may also be interested in...
A new pre-assessment service for COVID-19 clinical trials that was established by the UK medicines regulator to cut down on review times is being extended to a limited number of other kinds of trials.
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.